Read More

Q+A: How Health Care Is Being ‘Disrupted’ in West Philadelphia

In early summer of 2021, Loretta Sweet Jemmott, PhD, was unanimously selected to receive the Lazarex Cancer Foundation Disruptor Award for being an individual who has responded with urgency, taking action to combat low minority participation in cancer clinical trials and has disrupted the current status quo by raising awareness about existing problems, putting patients’ interests first and demonstrating a commitment to working on solutions.